Showing results (351-360 of 447) with videos related to

Sort By:
Pageof 45
Headache|October 13, 2022
Post hoc analysis of clinical trial data and pharmacokinetic data to assess wearing-off of erenumab within monthly treatment cycleDavid W Dodick, Andrew M Blumenfeld, Rashmi B Halker Singh, et al.
Headache|April 1, 2022
Challenges and complexities in designing cluster headache prevention clinical trials: A narrative reviewDavid W Dodick, Peter J Goadsby, Messoud Ashina, et al.
JAMA Network Open|June 8, 2022
Rates of Response to Atogepant for Migraine Prophylaxis Among Adults: A Secondary Analysis of a Randomized Clinical TrialRichard B Lipton, Patricia Pozo-Rosich, Andrew M Blumenfeld, et al.
Cephalalgia : an International Journal of Headache|February 14, 2020
Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatmentDavid W Dodick, Peter J Goadsby, Christian Lucas, et al.
JAMA Neurology|December 20, 2017
Effect of Different Doses of Galcanezumab vs Placebo for Episodic Migraine Prevention: A Randomized Clinical TrialVladimir Skljarevski, Tina M Oakes, Qi Zhang, et al.
Mayo Clinic Proceedings|July 13, 2005
Sinus headache: a neurology, otolaryngology, allergy, and primary care consensus on diagnosis and treatmentRoger K Cady, David W Dodick, Howard L Levine, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 28, 2006
An otolaryngology, neurology, allergy, and primary care consensus on diagnosis and treatment of sinus headacheHoward L Levine, Michael Setzen, Roger K Cady, et al.
Diagnostics (Basel, Switzerland)|August 10, 2024
Baseline Normative and Test-Retest Reliability Data for Sideline Concussion Assessment Measures in YouthJennifer V Wethe, Jamie Bogle, David W Dodick, et al.
Pain|July 20, 2012
Activation of TRPA1 on dural afferents: a potential mechanism of headache painRebecca M Edelmayer, Larry N Le, Jin Yan, et al.
Pageof 45